Safety and Efficacy of the Multitargeted Receptor Kinase Inhibitor Pazopanib in the Treatment of Corneal Neovascularization

PURPOSE. To evaluate the safety and efficacy of topical pazopanib in the treatment of corneal neovascularization (CNV). METHODS. Twenty eyes of 20 patients with stable CNV were enrolled in a prospective, open label, noncomparative study and treated with topical pazopanib 0.5% for 3 weeks, and follow...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Amparo, Francisco, Sadrai, Zahra, Jin, Yiping, Alfonso-Bartolozzi, Belen, Wang, Haobing, Shikari, Hasanain, Ciolino, Joseph B., Chodosh, James, Jurkunas, Ula, Schaumberg, Debra A., Dana, Reza
Médium: Artigo
Jazyk:Inglês
Vydáno: The Association for Research in Vision and Ophthalmology 2013
Témata:
Clinical Trials
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558296/
https://ncbi.nlm.nih.gov/pubmed/23233252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.12-11032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky